Malaria Vaccine Antibodies in Children
Author Information
Author(s): Dodoo Daniel, Atuguba Frank, Bosomprah Samuel, Ansah Nana Akosua, Ansah Patrick, Lamptey Helena, Egyir Beverly, Oduro Abraham R, Gyan Ben, Hodgson Abraham, Koram Kwadwo A
Primary Institution: Noguchi Memorial Institute for Medical Research, University of Ghana
Hypothesis
Can antibody levels to malaria vaccine candidate antigens correlate with protection from clinical malaria in children?
Conclusion
A multivalent vaccine involving different antigens is likely to be more effective than a monovalent one.
Supporting Evidence
- IgG levels generally increased with age.
- The risk of clinical malaria decreased with increasing antibody levels.
- Higher IgG levels were associated with reduced risk of clinical malaria.
Takeaway
The study looked at how antibodies in children's blood can help protect them from malaria. It found that having more antibodies can mean less chance of getting sick.
Methodology
The study used a multiplex assay to measure IgG antibody levels to 10 malaria antigens in 325 children aged 1 to 6 years and related these levels to the risk of clinical malaria over one year.
Potential Biases
Potential bias in self-reported symptoms and reliance on parental reporting for clinical episodes.
Limitations
The study only included children aged 1 to 6 years and may not be generalizable to older populations.
Participant Demographics
Children aged 1 to 6 years from the Kassena-Nankana district in Northern Ghana.
Statistical Information
P-Value
0.02
Confidence Interval
[95% C.I.= 0.73, 0.97]
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website